Product Code: ETC6272810 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Non-24-Hour Sleep-Wake Disorder (Non-24) is a condition where an individuals circadian rhythm does not align with the 24-hour day, leading to significant disruptions in sleep patterns. The treatment market for Non-24 includes medications such as melatonin agonists and other circadian rhythm modulators. In Bahrain, the prevalence of this condition is relatively low but expected to increase as awareness grows. The market is driven by the need for targeted therapies that help individuals with Non-24 manage their sleep cycles effectively. As the healthcare sector continues to advance, new treatment options are likely to emerge, further expanding the market.
Although still a niche segment, the market for Non-24-Hour Sleep-Wake Disorder drugs in Bahrain is growing as sleep disorders become more commonly diagnosed, especially among the visually impaired population. Increased awareness, coupled with the availability of specialized pharmaceuticals like melatonin receptor agonists, is driving demand. The presence of sleep clinics and improved diagnostic technologies are helping physicians provide targeted treatments, while telemedicine platforms also play a role in broader access to these therapies.
The Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market faces challenges due to the limited awareness and understanding of the disorder. Non-24-Hour Sleep-Wake Disorder, which affects individuals who are blind or have impaired vision, can be difficult to diagnose and treat. The market for drugs addressing this condition is niche, as it primarily affects a small subset of the population. Additionally, the limited availability of approved treatments and the high cost of specialized drugs make it challenging to provide effective solutions for patients. Research and development efforts in this area are also constrained by the small patient population, which can make clinical trials less viable. Regulatory hurdles for new drug approvals in this category further complicate market growth.
Targeting the visually impaired and individuals with circadian rhythm disorders, this niche pharmaceutical segment is emerging in Bahrain. Drug developers and distributors can benefit by aligning with sleep disorder clinics and hospitals offering neuropsychiatric care.
Treatment for circadian rhythm disorders like Non-24-Hour Sleep-Wake Disorder is emerging in Bahrains sleep medicine sector. The NHRA has started recognizing specialty pharmaceuticals such as melatonin receptor agonists. Imported drugs must undergo a registration process, and sleep disorder management is supported in tertiary hospitals. The government is promoting awareness and diagnosis through continuing education for healthcare professionals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By Types |
6.1 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021- 2031F |
6.1.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hypernychthemeral Syndrome, 2021- 2031F |
6.1.5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Shift Work Disorder, 2021- 2031F |
6.1.6 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Jet Lag and Others, 2021- 2031F |
6.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Therapeutic Devices, 2021- 2031F |
6.2.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Nonbenzodiazepines, 2021- 2031F |
6.3.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.3.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.5.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Wellness Centers and Spa, 2021- 2031F |
6.5.6 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Import-Export Trade Statistics |
7.1 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Export to Major Countries |
7.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Imports from Major Countries |
8 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
9 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
9.1 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
10.1 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |